# Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops

> **NCT03911531** · — · RECRUITING · sponsor: **Thomas Jefferson University** · enrollment: 55 (estimated)

## Conditions studied

- Nonimmune Fetal Hydrops
- Nonimmune Hydrops in Neonate
- Genetic Disorders

## Interventions

- **DIAGNOSTIC_TEST:** Whole Exome Sequencing
- **DIAGNOSTIC_TEST:** Whole Genome Sequencing

## Key facts

- **NCT ID:** NCT03911531
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-15
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911531, "Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03911531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*